Bridgeway Capital Management’s OptimizeRx OPRX Stock Holding History

Bridgeway Capital Management’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$339K	Sell	54,029 -15,000	-22%	-$139K	0.01%	903
2025 Q4	$846K	Buy	69,029 +10,000	+17%	+$163K	0.02%	731
2025 Q3	$1.21M	Sell	59,029 -40,000	-40%	-$635K	0.03%	669
2025 Q2	$1.34M	Hold	99,029	–	–	0.03%	608
2025 Q1	$858K	Sell	99,029 -55,071	-36%	-$337K	0.02%	665
2024 Q4	$749K	Hold	154,100	–	–	0.02%	727
2024 Q3	$1.19M	Hold	154,100	–	–	0.03%	637
2024 Q2	$1.54M	Buy	154,100 +43,100	+39%	+$473K	0.04%	577
2024 Q1	$1.35M	Sell	111,000 -13,700	-11%	-$199K	0.03%	663
2023 Q4	$1.78M	Buy	124,700 +40,600	+48%	+$390K	0.04%	621
2023 Q3	$654K	Buy	+84,100	New	+$915K	0.02%	813

Other funds holding OPRX

WCA

Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bridgeway Capital Management's OPRX Position: Q1 2026 in Review

Bridgeway Capital Management reduced its OptimizeRx (OPRX) stake by 22% in Q1 2026, selling an estimated $139K and leaving 54,029 shares worth $339K. The position accounts for 0.01% of the portfolio, ranked #903.

Bridgeway Capital Management first reported a position in OPRX in Q3 2023 and has held it in 11 quarters since. The position peaked at $1.78M in Q4 2023. 128 funds tracked by Wall St. Rank hold OPRX as of Q1 2026.

Bridgeway Capital Management held 54,029 shares of OptimizeRx worth $339K as of Q1 2026.
Bridgeway Capital Management sold 15,000 OptimizeRx shares in Q1 2026, an estimated $139K.
OptimizeRx made up 0.01% of Bridgeway Capital Management's portfolio in Q1 2026, its #903 holding.
Bridgeway Capital Management first reported a position in OptimizeRx in Q3 2023 and has held it in 11 quarters since.
Bridgeway Capital Management's OptimizeRx position peaked at $1.78M in Q4 2023.
128 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2026.

Based on Bridgeway Capital Management's 13F filing for Q1 2026, filed 15 May 2026.